A Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
A passed our risk checks.
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$101.17 |
| 52 Week High | US$160.27 |
| 52 Week Low | US$96.80 |
| Beta | 1.03 |
| 1 Month Change | -9.52% |
| 3 Month Change | -17.40% |
| 1 Year Change | -26.87% |
| 3 Year Change | -3.87% |
| 5 Year Change | 53.50% |
| Change since IPO | 136.66% |
Recent News & Updates
Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26
Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Recent updates
Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely
Apr 17Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Apr 03Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Mar 21Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment
Mar 09Agilent Technologies declares $0.225 dividend
Feb 22Fluor's unit gets contract to expand Agilent's manufacturing facility in Colorado
Feb 16Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Jan 30Agilent Technologies: A Proven Track Record Of Shareholder Value Creation, Hold
Jan 16Agilent to acquire Avida for cancer research
Jan 04Agilent Technologies (NYSE:A) Has A Rock Solid Balance Sheet
Dec 30Agilent's liquid biopsy test gets FDA nod for companion diagnostic test to Mirati's Krazati
Dec 13Agilent Technologies raises quarterly dividend by 7.1% to $0.225/share
Nov 16Is Agilent Technologies, Inc. (NYSE:A) Worth US$138 Based On Its Intrinsic Value?
Nov 08Why Agilent Technologies, Inc. (NYSE:A) Could Be Worth Watching
Oct 26Here's Why Agilent Technologies (NYSE:A) Has Caught The Eye Of Investors
Oct 02Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?
Sep 19Agilent Confirmed Its Leadership And Is Set For Further Gains (Technical Analysis)
Sep 14Agilent, Mettler-Toledo team up for solution to reduce errors in sample preparation
Sep 01Agilent Technologies: Turning Bullish Ahead Of Q3 Earnings
Aug 11Agilent Technologies acquires Polymer Standards Service; terms undisclosed
Aug 02Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 31Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Jul 18Agilent cut to Neutral at Citi on macro headwinds
Jul 08Agilent Technologies Valuation Just Re-Entered 'Buy' Territory
Jun 27Agilent Technologies (NYSE:A) Seems To Use Debt Rather Sparingly
Jun 21Should You Be Adding Agilent Technologies (NYSE:A) To Your Watchlist Today?
May 31Shareholder Returns
| A | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -7.5% | -7.6% | -1.2% |
| 1Y | -26.9% | -20.0% | 5.9% |
Return vs Industry: A underperformed the US Life Sciences industry which returned -18.6% over the past year.
Return vs Market: A underperformed the US Market which returned 4.1% over the past year.
Price Volatility
| A volatility | |
|---|---|
| A Average Weekly Movement | 3.4% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.7% |
Stable Share Price: A is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: A's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 18,300 | Mike McMullen | https://www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.
Agilent Technologies, Inc. Fundamentals Summary
| A fundamental statistics | |
|---|---|
| Market Cap | US$29.60b |
| Earnings (TTM) | US$1.13b |
| Revenue (TTM) | US$6.99b |
26.1x
P/E Ratio4.2x
P/S RatioIs A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A income statement (TTM) | |
|---|---|
| Revenue | US$6.99b |
| Cost of Revenue | US$3.43b |
| Gross Profit | US$3.56b |
| Other Expenses | US$2.43b |
| Earnings | US$1.13b |
Last Reported Earnings
Jul 31, 2023
Next Earnings Date
Nov 20, 2023
| Earnings per share (EPS) | 3.87 |
| Gross Margin | 50.93% |
| Net Profit Margin | 16.20% |
| Debt/Equity Ratio | 50.2% |
How did A perform over the long term?
See historical performance and comparison